Vaccine Contract Manufacturing Market Headed for Growth and Global Expansion by 2026 | Soligenix Inc., Bavarian Nordic A/S, Goodwin Biotechnology Inc., BioMARK, Emergent BioSolutions, Catalent Biologics

Pharmaceutical and biopharmaceutical companies are focusing more on their respective core strengths to manage the rising price pressure. Thus, the demand for contract manufacturing is increasing. However, vaccine manufacturing is a complex venture, in which safety, effectivity, and consistency are the most challenging part for the manufacturers. It offer many services that include production process, construction and operation of manufacturing product, cell line development, fermentation, process optimization, and analytical characterization, which fuels growth of the global vaccine contract manufacturing market.

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/1083

Global Vaccine Contract Manufacturing Market Taxonomy:

On the basis of service type, vaccine type, and product type, the global vaccine contract manufacturing market is segmented into,

By Service Type:
Fill-Finish
Bulk product

By Vaccine Type:
Subunit Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Inactivated Vaccines
Recombinant Vector Vaccines
Toxoid Vaccines
Synthetic Vaccines

By Product Type:
Single Vaccine
Ebola Virus
Influenza Virus
Smallpox
Chickenpox
Tetanus
Polio
Tuberculosis
Others
Combination Vaccine

Competitive Landscape

The key players operating in the global vaccine contract manufacturing market include Soligenix Inc., Bavarian Nordic A/S, Goodwin Biotechnology Inc., BioMARK, Emergent BioSolutions, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, Thomas Jefferson University, and Minneapolis Medical Research Foundation (MMRF).

Request For Customization Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-customization/1083

Increase in research activities for new vaccines and availability of funds for the same could be the key growth factor of vaccine contract manufacturing market

Soligenix Inc. received a fund of around US$ 2.5 million for the contract of bioterror vaccine from National Institute of Allergy and Infectious Diseases (NIAID) in August 2017. The fund is granted for good manufacturing practices (GMP) of RiVax bulk drug substances and finished drug manufacturing to conduct future preclinical, clinical, and efficacy studies. Soligenix is aiming to develop advanced Soligenix's thermostabilization technology (ThermoVax) in combination with ricin toxin vaccine candidate – RiVax. The studies are conducting to prevent the effects of ricin exposure.

Emergent BioSolutions agreed to sign a contract with the Centers for Disease Control and Prevention (CDC) for the manufacturing of BioThrax anthrax vaccine in 2016. According to the contract, Emergent will supply over 29 million doses of BioThrax anthrax vaccine in five years period of worth around US$ 911 million. Moreover, Biomedical Advanced Research and Development Authority planned to order more Bio Thrax worth US$ 100 million. This would further augment growth of the global vaccine contract manufacturing market in the near future.

Increasing Prevalence Of Various Viral And Bacterial Infections Is Expected To Fuel Growth Of The Market

According to World Health Organization (WHO), in 2016, around three to five million cases were recorded with severe illness and around 250,000 to 500,000 deaths were estimated due to influenza worldwide.

In 1952, Centers for Disease Control and Prevention (CDC) collaborated with the World Health Organization’s (WHO), under the program - Global Influenza Surveillance and Response System (GISRS). The GISRS network consist of around 142 National Influenza Centers (NICS) worldwide, which are conducting influenza surveillance and viral trends in 112 countries. The study helps in research and analysis of influenza pattern and may contribute to develop candidate vaccines. This in turn, fuels growth of the vaccine contract manufacturing market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.